Abstract
The transcription factor NF-κB and type I interferon (IFN) are both important modulators of the innate immune system. NF-κB plays a key role in the up-regulation of pro-inflammatory cytokines, adhesion molecules and chemokines (Oncogene 25:6758–6780, 2006), whereas type I IFN is essential for the initiation of an antiviral state in cells, and for the detection of malignant cells (Microbes Infect 4(6):647–655, 2002).
This chapter summarizes the inhibitory mechanisms both endogenous and from pathogens that target NF-κB and the type I IFN system. Without internal regulatory systems, deregulated NF-κB and type I IFN can cause inflammatory diseases and malignancy in cells. Pathogens also target both signalling systems to replicate within the host.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Alexander WS, Hilton DJ (2004) The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol 22:503–529
Andrejeva J et al (2004) The V proteins of paramyzoviruses bind the IFN-inducible RNA helicase, mda-5 and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 101:17264–17269
Annunziata CM et al (2007) Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12:115–130
Baetz A et al (2004) Suppressor of cytokine signaling (SOCS) proteins indirectly regulate Toll-like receptor signalling in innate immune cells. J Biol Chem 279(52):54708–54715
Basler CF et al (2003) The Ebola virus vp35 protein inhibits activation of interferon regulatory factor 3. J Virol 77:7945–7956
Bauhofer O et al (2005) Role of double-stranded RNA and Npro of classical swine fever virus in the activation of monocyter-derived dendritic cells. Virology 343:93–105
Bayert R et al (2000) A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappaB dependent gene expression and apoptosis. Biochem Pharmacol 60:1143–1151
Bignell GR et al (2000) Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 25:160–165
Boone DL et al (2004) The ubiquitin-modifying enzyme A20 is required for termination of TOll-like receptor responses. Nat Immunol 5:1052–1060
Bossert B et al (2003) Nonstructural protein NS1 and NS2 of bovine respiratory syncytial virus blocks activation of interferon regulatory factor 3. J Virol 77:8661–8668
Brierley MM et al (2002) Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry. J Interferon Cytokine Res 22:835–845
Brummelkamp TR et al (2003) Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424:797–801
Brzozka K, Finke S, Conzelmann KK (2005) Identification of rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulator factor 3. J Virol 79(12):7613–7681
Capili AD et al (2001) Solution structure of the PHD domain from the KAP-1 corepressor: structural determinants for PHD, RING and LIM zinc-binding domains. EMBO J 20:165–177
Caraglia M et al (2005) Alpha-interferon and its effects on signal transduction pathways. J Cell Physiol 202:323–335
Cardenas WB, Loo YM et al (2006) Ebola virus VP35 protein binds double stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signalling. J Virol 80(11):5168–5178
Carmody RJ et al (2007) Negative regulation of toll-like receptor signalling by NF-κB p50 ubiquitination blockade. Science 317:657–678
Chen Z et al (1995) Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev 9:1586
Childs K et al (2007) Mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359:190–200
de Vries W, Haasnoot J et al (2009) Differential RNA silencing suppression activity of NS1 proteins from different influenza A strains. J Gen Virol 90:1916–1922
Evans PC et al (2004) Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem J 378:727–734
Gale M Jr, Blakely CM et al (1998) Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms in kinase regulation. Mol Cell Biol 18:5208–5218
Garcia-Sastre A (2002) Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses. Microbes Infect 4(6):647–655
Ghosh S, Hayden MS (2008) New regulators of NF-kappaB in inflammation. Nat Rev Immunol 8:837–848
Guiducci C et al (2008) Signalling pathways leading to IFN-alpha production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications. J Intern Med 265:43–57
Haasnoot J et al (2007) The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog 3(6 e86):0794–0803
Hatada E, Fukuda R (1992) Binding of influenza A virus NS1 protein to dsRNA in vitro. J Gen Virol 73:3325–3329
Hayden MS, West AP et al (2006) NF-kappaB and the immune response. Oncogene 25:6758–6780
Heyninck K, Beyaert R (2005) A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions. Trends Biochem Sci 30(1):1–4
Heyninck K et al (1999) The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN. J Cell Biol 135:1471–1482
Ho HH, Ivashkiv LB (2006) Role of STAT3 in type I interferon responses – negative regulation of STAT1-dependent inflammatory gene activation. J Biol Chem 281(30):14111–14118
Hoffman A et al (2002) The IκB-NF-κB signaling module: temporal control and selective gene activation. Science 298:1241–1245
Honda K et al (2004) Role of transductional transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci USA 101:15416–15421
Hooks JJ et al (1979) Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 301:5–8
Isaacs A, Lindenmann J (1957) Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147(927):258–267
Jin W et al (2008) Deubiquitinating enzyme CYLD regulates RANK signaling and osteoclastogenesis. J Clin Investig 118:1858–1866
Kagan JCS et al (2008) TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 9(4):361–368
Kanneganti TD et al (2007) Intracellular NOD-like receptors in host defense and disease. Immun Rev 27:549–559
Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441:431–436
Katakura K et al (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Investig 115:695–702
Kawai T, Akira S (2008) Toll-like receptor and RIG-I like receptor signalling. Ann NY Acad Sci 1143:1–20
Kayagaki NP et al (2007) Science 318:1628
Keats JJ et al (2007) Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 12:131–144
Kovalenko A et al (2003) The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424:801–805
Kuwata H et al (2006) IκBNS inhibits induction of a subset of Toll-like receptor-dependent genes and limits inflammation. Immunity 24:41–51
La Rocca SA et al (2005) Loss of interferon regulator factor 3 in cells infected with classical swine fever virus involves the N-terminal protease, Npro. J Virol 79:7127–7147
Lee EG et al (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20 deficient mice. Science 289:2350–2354
Li S et al (1999) The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18:5727–5737
Lin RH et al (1998) Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18:2986–2996
Lin RM et al (1999) Structural and functional analysis of interferon regulatory factor 3: localisation of the transactivation and autoinhibitory domains. Mol Cell Biol 19:2465–2474
Lin R et al (2001) HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 20:800–811
Liu YJ (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23:275–306
Lu KP et al (1996) A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380(6574):544–547
Lu B et al (2005) Negative regulation of NF-κB signalling by PIAS1. Mol Cell Biol 25:1113–1125
Maine G et al (2007) COMMD1 promotes the ubiquitination of NF-κB subunits through a cullin-containing ubiquitin ligase. EMBO J 26:436–447
Makarova KS et al (2000) A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pheumoniae. Trends Biochem Sci 25:50–52
Meylan E et al (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167–1172
Mibayashi M et al (2007) Inhibition of retinoic acid-inducible gene -I- mediated induction of interferon-{beta} by the NS1 protein of influenza A virus. J Virol 81:514–524
Motoyama Y et al (2005) Positive and negative regulation of nuclear factor-κB mediated transcription by IκBζ, an inducible nuclear protein. J Biol Chem 280:7444–7451
Muhlbauer M et al (2008) Impaired Bcl3 up-regulation leads to enhanced lipopolysaccharide-induced interleukin (IL)-23-p19 gene expression in IL-10 −/− mice. J Biol Chem 283:14182–14189
Nakagawa R et al (2002) SOCS-1 participates in negative regulation of LPS response. Immunity 17:677–687
Opipari AW Jr et al (1990) The A20 CDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem 265:14705–14708
Park J et al (2000) 275:6764–6769
Peter J et al (2006) The pathogenic NY-1 Hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1- directed interferon responses. J Virol 80(19):9676–9686
Qin BY, Liu C et al (2003) Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat Struct Biol 10:913–921
Reiley W et al (2005) Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation. Mol Cell Biol 25:3886–3895
Ronco LV et al (1998) Human papilloma 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12:2061–2072
Ruggli N et al (2005) N(pro) of classical swine fever virus is an antagonist of double stranded RNA-mediated apoptosis and IFN-alpha/beta induction. Virology 340:265–276
Rumenapf T et al (1998) N-terminal protease of pestiviruses: identification of putative catalytic residues by site directed mutagenesis. J Virol 72:2544–2547
Saitoh T et al (2006) Negative regulation of interferon-regulatory factor 3- dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol 7(6):598–605
Seth RB et al (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122(5):669–682
Sheedy FJ, O’Neill LA (2007) The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling. J Leukocyte Biol 82:196–203
Stojdl DF et al (2003) VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4(4):263–275
Taganov KD et al (2006) NF-kappaB dependent induction of microRNA miR146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103:12481–12486
Taganov KD et al (2007) MicroRNAs and immunity: tiny players in a big field. Immunity 26:133–137
Takaoka A, Taniguchi T (2003) New aspects of IFN-alpha/beta signalling in immunity, oncogenesis and bone metabolism. Cancer Sci 94:405–411
Talon J et al (2000) Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74:7989–7996
Tanaka T et al (2007) PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol 8(6):584–591
Tang Y et al (2009) MicroRNA-146a contributes to abnormal activation of type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 60(4):1065–1075
Trompouki E et al (2003) CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424:793–796
Van Huffel S et al (2001) Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2. J Biol Chem 276:30216–30223
Wang X et al (2000) Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 74(24):11566–11573
Wertz IE et al (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430:694–699
Wessells J et al (2004) BCL-3 and NF-κB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J Biol Chem 279:49995–50003
Wooten MW et al (2008) Essential role of sequestosome 1/p62 in regulating accumulation of Lys63-ubquitinated proteins. J Biol Chem 283:6783–6789
Wulf G et al (2005) Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat Cell Biol 7(5):435–441
Wullaert A et al (2007) LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-κB activation. J Biol Chem 282(1):81–90
Yamamoto M, Takeda K, Akira S (2004) TIR domain containing adaptors define specificity of TLR signalling. Mol Immunol 40(12):861–868
Yoneyama MS et al (1998) Direct triggering of type I interferon system by virus infection: activation of a transcription factor complex containing IRF3 and CBP/p300. EMBO 17:1087–1095
Yoshida H et al (2005) The tumor suppressor CYLD acts as a negative regulator for toll-like receptor 2 signalling via negative cross-talk with TRAF6 and TRAF7. J Biol Chem 280:41111–41121
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Murphy, C., O’Neill, L.A.J. (2012). Negative Regulators of NF-κB Activation and Type I Interferon Pathways. In: Wang, R. (eds) Innate Immune Regulation and Cancer Immunotherapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9914-6_15
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9914-6_15
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-9913-9
Online ISBN: 978-1-4419-9914-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)